Vaxcell-Bio Therapeutics Co., Ltd.

KOSDAQ:A323990 Stock Report

Market Cap: ₩331.3b

Vaxcell-Bio Therapeutics Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Vaxcell-Bio Therapeutics.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth64.9%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

We Think Vaxcell-Bio Therapeutics (KOSDAQ:323990) Can Afford To Drive Business Growth

Jul 29
We Think Vaxcell-Bio Therapeutics (KOSDAQ:323990) Can Afford To Drive Business Growth

We're Interested To See How Vaxcell-Bio Therapeutics (KOSDAQ:323990) Uses Its Cash Hoard To Grow

Apr 01
We're Interested To See How Vaxcell-Bio Therapeutics (KOSDAQ:323990) Uses Its Cash Hoard To Grow

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Vaxcell-Bio Therapeutics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A323990 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202470-10,432-12,869-10,555N/A
3/31/202440-10,482-11,602-10,639N/A
12/31/202314-10,274-9,621-9,423N/A
9/30/2023N/A-9,689-8,704-8,603N/A
6/30/2023N/A-8,554-7,257-7,033N/A
3/31/2023N/A-7,383-6,596-6,373N/A
12/31/2022N/A-6,825-6,335-6,045N/A
9/30/2022N/A-6,039-7,373-5,449N/A
6/30/2022N/A-5,667-7,764-5,749N/A
3/31/2022N/A-5,672-7,503-5,373N/A
12/31/2021N/A-4,763-6,890-4,662N/A
9/30/2021N/A-4,482-5,639-5,077N/A
6/30/2021N/A-4,059-4,327-3,974N/A
3/31/2021N/A-3,597-3,837-3,607N/A
12/31/2020N/A-3,984-3,335-3,303N/A
9/30/2020N/A-3,959-4,088-3,724N/A
6/30/2020N/A-1,107-4,528-4,042N/A
3/31/2020N/A-1,329-4,609-3,925N/A
12/31/2019N/A-1,254-4,492-3,589N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A323990's forecast earnings growth is above the savings rate (2.6%).

Earnings vs Market: Insufficient data to determine if A323990's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A323990's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A323990's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A323990's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if A323990's Return on Equity is forecast to be high in 3 years time


Discover growth companies